Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,020 recruiting studies in this area right now.
By phase
- Not applicable2,809
- Phase 2750
- Phase 1522
- Phase 3382
- Phase 1/Phase 2294
- Phase 4204
- Phase 2/Phase 359
Top conditions
- Breast Cancer1,191
- Melanoma173
- Metastatic Breast Cancer138
- Rheumatoid Arthritis131
- Atopic Dermatitis124
- Systemic Lupus Erythematosus119
- Breast Neoplasms111
- Triple Negative Breast Cancer111
- Colorectal Cancer93
- Ovarian Cancer91
- Psoriasis85
- Breast Carcinoma79
- Lung Cancer77
- Prostate Cancer69
- Rheumatoid Arthritis (RA)68
- Diabetic Foot Ulcer59
- Cancer58
- Systemic Lupus Erythematosus (SLE)52
Leading sponsors
- Fudan University64
- M.D. Anderson Cancer Center51
- Novartis Pharmaceuticals49
- Memorial Sloan Kettering Cancer Center48
- Mayo Clinic40
- AstraZeneca38
- Assistance Publique - Hôpitaux de Paris37
- National Cancer Institute (NCI)37
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34
- Second Affiliated Hospital, Zhejiang University, School of Medicine30
Where studies are running
- California408
- Arizona151
- Alabama130
- Florida125
- New York111
- Texas106
- Maryland94
- Massachusetts87
- Pennsylvania72
- North Carolina68
Recruiting studies5,020 total
- NCT06638827Recruiting
Surgery for severe hand sweating
This trial tests a surgery called bilateral thoracoscopic sympathectomy to treat severe, unexplained sweating of the hands and face. It aims to see if the surgery improves quality of life and reduces sweating.
Sohag, Sohag GovernorateAges 15 years+ - NCT07710443Recruiting
Mosaic Filler Trial for Midface Volume Loss
This trial tests a new cheek filler called Mosaic for people with moderate to severe cheek volume loss. It helps doctors see if Mosaic is safe and effective for filling out the midface area.
Bradenton, FloridaAges 22 years+ - NCT07712939RecruitingPhase 1
Study of CND319 for rheumatic diseases
This study tests a new drug called CND319 in healthy volunteers and people with rheumatoid arthritis or Sjögren's disease. The goal is to see if it is safe and how the body responds to it.
Melbourne, VictoriaAges 18–65 - NCT07712523RecruitingPhase 2
Testing QY201 tablets for non-segmental vitiligo
This trial tests an experimental oral tablet called QY201 to see if it can improve vitiligo (white patches on the skin). It is for adults with non-segmental vitiligo, regardless of whether the patches are currently growing or stable.
Shenyang, LiaoningAges 18–65 - NCT07711418RecruitingPhase 3
A study of rezpegaldesleukin for teenagers and adults with moderate-to-severe eczema
This trial tests an investigational drug called rezpegaldesleukin for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't improved enough with topical treatments. The goal is to see if it can safely reduce eczema symptoms.
Birmingham, AlabamaAges 12 years+ - NCT07708194RecruitingPhase 1/Phase 2
Entinostat plus pyrotinib and hormone therapy for advanced breast cancer
This trial tests a new combination of two targeted drugs (entinostat and pyrotinib) with hormone therapy for people with advanced, triple-positive breast cancer whose disease has progressed after trastuzumab (Herceptin). The goal is to see if this approach works better than current options.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07714278Enrolling by invitation
Video-based rehab for chemotherapy nerve damage
This study tests a personalized rehab program using video analysis to help people with chemotherapy-induced nerve damage (numbness, tingling, weakness) improve their walking and daily life.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07706556Recruiting
Remote activity program for breast cancer survivors
This trial tests a new program to help breast cancer survivors become more active. The program is delivered remotely using a smartphone app, and it adjusts based on your progress. It may be a good fit if you finished treatment less than 5 years ago and are not very active yet.
Lebanon, New HampshireAges 18 years+ - NCT07707817Recruiting
Expanding preventive medicine access for mobile groups
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
Ondo, Ondo, Taraba and Akwa IbomAges 5 years+ - NCT07708896Recruiting
Evolution of chronic skin diseases
This trial looks at how well standard treatments work for chronic skin conditions like atopic dermatitis, prurigo nodularis, psoriasis, chronic hand eczema, and hidradenitis suppurativa. It's observational, so it just tracks your progress during your normal care.
RomeAges 12 years+ - NCT07707726Recruiting
Virtual reality for ingrown toenail surgery
This study tests if using virtual reality (VR) during ingrown toenail surgery can help reduce anxiety or pain. It might be an option for people having this surgery at a specific hospital in Turkey.
Ankara, AnkaraAges 18–65 - NCT06642870Recruiting
Self-management programme for rare rheumatic conditions
This trial is developing a self-management programme for people with rare rheumatic conditions like lupus, vasculitis, myositis, or Sjogren syndrome. It aims to help participants better manage their condition and improve their quality of life.
BristolAges 18 years+ - NCT06642948Recruiting
AI system for exercise rehab in breast cancer survivors
This study tests a new AI-based skeleton recognition system to guide rehabilitation exercises for breast cancer survivors. It may help reduce pain and improve mobility for those taking aromatase inhibitors.
ShanghaiAges Any age - NCT06641544RecruitingPhase 4
Testing different drug combos for HER2-positive breast cancer
This trial tests different combinations of the drug Inetetamab as a first treatment for breast cancer that has spread and is HER2-positive. It aims to find which combo works best and is safe for newly diagnosed metastatic patients.
Shanwei, GuangdongAges 18–70 - NCT04605146Recruiting
Telemonitoring to manage side effects from immunotherapy
This trial tests whether using home digital monitoring (telemonitoring) can help people with melanoma, lung, or kidney (renal) cancer manage side effects while on immunotherapy. It may help catch side effects earlier and support you during treatment with nivolumab plus ipilimumab or nivolumab alone.
BronAges 18 years+ - NCT04981145RecruitingPhase 4
Iguratimod for Sjögren’s syndrome symptoms and safety
This trial studies whether iguratimod improves symptoms in people with primary Sjögren’s syndrome, and checks how safe it is. It focuses on people with confirmed disease markers (anti-SSA/Ro-60) and ongoing dry eyes and dry mouth.
Hangzhou, ZhejiangAges 18–70 - NCT06639178Recruiting
Cream to prevent hand-foot syndrome from capecitabine in breast cancer
This trial tests whether a special cream containing N-acetylcysteine and urea can prevent the painful hand-foot syndrome often caused by the chemotherapy drug capecitabine. If you have breast cancer and are about to start capecitabine, this study may help reduce side effects.
Aviano, PordenoneAges 18 years+ - NCT06640309RecruitingPhase 2
Nicotinamide for rheumatoid arthritis: a clinical trial
This trial tests if taking a vitamin B3 supplement (nicotinamide) can improve outcomes for people with rheumatoid arthritis. Researchers want to see if adding this over-the-counter vitamin to your usual arthritis medicines helps reduce disease activity.
CairoAges 18–65 - NCT06642363RecruitingPhase 1
Astaxanthin for PCOS symptoms and heart health
This trial tests if astaxanthin, a natural antioxidant, can improve PCOS symptoms and heart-related health in women with PCOS who are overweight but not pregnant or breastfeeding.
Isfahan, IsfahanAges 18–45 - NCT06498089RecruitingPhase 4
Comparing tailored vs. standard treatment for active Takayasu's arteritis.
This trial compares a personalized treatment plan based on your specific disease markers to standard care, aiming to find which is more effective and safer for active Takayasu's arteritis. It may help researchers learn how to better control inflammation and prevent flares.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06274892Recruiting
Using an app to improve radiotherapy check-ins
This study tests whether using a mobile app to report symptoms during radiation treatment helps doctors better support patients. It is for people with breast or prostate cancer starting radiation therapy at Princess Margaret Cancer Centre.
Toronto, OntarioAges 18 years+ - NCT07701590Recruiting
New wound dressings for hard-to-heal leg and foot ulcers
This study tests a special amniotic membrane wound dressing compared to a synthetic wound matrix for stubborn diabetic foot ulcers or venous leg ulcers. It may help if your wound has not been healing well for over a month.
San Diego, CaliforniaAges 18 years+ - NCT07702708Recruiting
AI predicts chemotherapy response in HR+/HER2- breast cancer
This trial uses AI to analyze your pre-treatment MRI and predict how well your tumor will respond to chemotherapy before surgery. It is for people with HR+/HER2- breast cancer who need chemo before their operation.
Fuzhou, FujianAges 18 years+ - NCT07700056RecruitingPhase 3
Study of remibrutinib for severe itching of unknown cause
This study tests an investigational medicine (remibrutinib) for people with severe itching that has no known cause. It may help reduce the itch when moisturizers haven't worked.
Miami, FloridaAges 18 years+
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,020 recruiting dermatology studies from the U.S. registry right now, out of 7,754 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.